Dermatology and Cosmetic
پوست و زیبایی
jdc
Medical Sciences
http://jdc.tums.ac.ir
1
admin
2008-7470
2228-7388
000
000
000
000
000
fa
jalali
1403
8
1
gregorian
2024
11
1
15
3
online
1
fulltext
fa
فراوانی ابتلا به ریزش موی تلوژن افلوویوم در زنان مبتلا به کووید ١٩ مراجعهکننده به درمانگاه پوست و مو بیمارستان امام رضا (ع) اردبیل
در سال 1401
Determining the frequency of telogen effluvium hair loss in female patients with covid-19 referred to Imam Reza hospital dermatology clinic at 2022
عمومى
General
پژوهشي
Research
<span style="font-size:10pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span bold="" class="AbstractBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold"><span lang="AR-SA" style="font-size:11.0pt"><span b="" mitra="" style="font-family:">زمینه و هدف:</span></span></span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> تلوژن افلوویوم (</span></span>TE<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:">) نوعی ریزش موی منتشر است که 2 تا 3 ماه پس از یک عامل استرسزا، ازجمله عفونت کووید 19، رخ میدهد. هدف این مطالعه تعیین فراوانی </span></span>TE<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> در زنان مبتلا به کووید 19 بود.</span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:6pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span lang="AR-SA" style="font-size:13.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:10pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span bold="" class="AbstractBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold"><span lang="AR-SA" style="font-size:11.0pt"><span b="" mitra="" style="font-family:">روش اجرا:</span></span></span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> این مطالعه توصیفی برروی 270 زن مراجعهکننده به درمانگاه پوست و مو بیمارستان امام رضا اردبیل با شکایت ریزش مو انجام شد. اطلاعات مربوط به سابقه ابتلا به کووید 19، بستری، داروهای مصرفی، دریافت واکسن و مشخصات دموگرافیک جمعآوری شد. شدت آلوپسی با معاینه بالینی و تست ترکشن بررسی شد و دادهها با نرمافزار </span></span>SPSS<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> تحلیل شدند.</span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:6pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span lang="AR-SA" style="font-size:13.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:10pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span bold="" class="AbstractBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold"><span lang="AR-SA" style="font-size:11.0pt"><span b="" mitra="" style="font-family:">یافته­ها:</span></span></span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> میانگین سن بیماران 41 سال بود. 1/61% سابقه بستری، 7/43% مصرف آنتیبیوتیک، 8/61% مصرف کورتیکواستروئید و 8/51% مصرف </span></span>NSAID<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> داشتند. شدت کووید 19 با بروز زودتر (001/0</span></span><span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic"><span dir="LTR" style="font-size:11.0pt">P</span></span></span>=<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:">) </span></span>TE<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> و افزایش تعداد موهای کندهشده در تست ترکشن (001/0</span></span><span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic"><span dir="LTR" style="font-size:11.0pt">P</span></span></span>=<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:">) ارتباط معناداری داشت. بستری بهدلیل کووید 19 و مصرف کورتیکواستروئید مدت زمان بین بیماری و شروع علائم </span></span>TE<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> را کاهش دادند. تزریق واکسن آسترازنکا با افزایش تعداد موهای کندهشده (02/0</span></span><span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic"><span dir="LTR" style="font-size:11.0pt">P</span></span></span>=<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:">) همراه بود.</span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:6pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span lang="AR-SA" style="font-size:13.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:10pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span bold="" class="AbstractBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold"><span lang="AR-SA" style="font-size:11.0pt"><span b="" mitra="" style="font-family:">نتیجه­گیری:</span></span></span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> شدت </span></span>TE<span lang="AR-SA" style="font-size:12.0pt"><span b="" mitra="" style="font-family:"> با شدت کووید 19، بستری، مصرف کورتیکواستروئید و تزریق واکسن آسترازنکا مرتبط بود.</span></span><span lang="FA" style="font-size:12.0pt"><span style="font-family:"B Mitra""></span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:110%"><span new="" roman="" style="font-family:" times=""><span bold="" class="NormalLeftBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold">Background and Aim:</span></span> Telogen effluvium (TE) is a type of diffuse hair loss that occurs 2 to 3 months after a stressful event, including a covid-19 infection. The aim of this study was to determine the frequency of TE in women with covid-19.<br>
<span bold="" class="NormalLeftBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold">Methods:</span></span> This descriptive study was conducted on 270 women who referred to the skin and hair clinic of Imam Reza Ardabil Hospital with complaints of hair loss. Information related to the history of covid-19 infection, hospitalization, medications, vaccination and demographic characteristics were collected. The severity of alopecia was checked by clinical examination and traction test, and the data were analyzed with SPSS software.<br>
<span bold="" class="NormalLeftBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold">Results:</span></span> The average age of the patients was 41 years. 61.1% had a history of hospitalization, 43.7% used antibiotics, 61.8% used corticosteroids, and 51.8% used NSAID. The severity of Covid-19 had a significant relationship with the earlier occurrence of TE (<span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic">P</span></span>=0.001) and the increase in the number of pulled hairs in the traction test (<span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic">P</span></span>=0.001). Hospitalization due to covid-19 and corticosteroid use reduced the time between illness and onset of TE symptoms. The injection of AstraZeneca vaccine was associated with an increase in the number of plucked hairs (<span class="NormalItalicChar" new="" roman="" style="font-family:" times=""><span style="font-style:italic">P</span></span>=0.02).</span></span></span><br>
<span bold="" class="NormalLeftBoldChar" new="" roman="" style="font-family:" times=""><span style="font-weight:bold"><span style="font-size:11.0pt">Conclusion:</span></span></span><span style="font-size:11.0pt"><span new="" roman="" style="font-family:" times=""> The severity of TE was related to the severity of covid-19, hospitalization, corticosteroid use and injection of AstraZeneca vaccine.</span></span>
ریزش مو, کووید 19, تلوژن افلوویوم, آلوپسی
hair loss, covid-19, telogen effluvium, alopecia
179
188
http://jdc.tums.ac.ir/browse.php?a_code=A-10-1-373&slc_lang=fa&sid=1
Majid
Rostami Moghaddam
مجید
رستمی مقدم
rostamimajid665@gmail.com